We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Thermophilic Archaeal Lipids Stabilize Drug-Delivery Liposomes

By LabMedica International staff writers
Posted on 18 Nov 2015
The possibility of using lipids extracted from microorganisms adapted to living in conditions of extreme heat and acidity to form liposomes for oral drug-delivery, which would able to survive passage through the harsh conditions of the stomach, was discussed in a recent paper.

To develop an oral drug delivery system suited to protect labile drug compounds like peptides and proteins against the harsh environment in the stomach and upper intestine, investigators at the University of Southern Denmark (Odense) prepared liposomes from phospholipids, cholesterol, and archaeal lipids. More...
As source for the archaeal lipids they used Sulfolobus islandicus, a hyperthermophilic archaeon, whose lipids have not been used in liposomes before.

S. islandicus requires an extreme environment that is 75–80 degrees Celsius hot with an acid pH of two to three. Due to the high temperatures, this organism needs to have extremely stable biomolecules in order to survive. Without increased stability in the membrane the cell would fall apart, and too many molecules would flow in and out of the membrane destroying the chemical gradients the cell uses as energy, while also allowing all the proteins the cell had synthesized to diffuse away, stopping the cell's metabolic processes.

The archaeal membrane still contains phosphate groups and long fatty acid tails, but they also contain ether linkages instead of ester linkages. The ether linkages make the bonds between phosphate groups and hydrocarbons more stable because the carbon connecting the phosphate group and glycerol molecule is more electron-rich than it would be in an ester, making that carbon less electrophilic and therefore less chemically reactive. This allows the ester-linked phospholipid to be more stable and less susceptible to breakdown from large amounts of increased thermal energy. This contributes to the archaea's ability to live in such extreme environments.

The investigators isolated cell membrane lipids from S. islandicus cultures and combined them with conventional phospholipids (from egg yolk or soybean oil) and cholesterol in order to make liposomes. The mixture contained 18% S. islandicus lipid molecules and 78% phospholipids/cholesterol. The liposomes were loaded with a dye, so their fate could be determined following exposure to bile salts from gastric juice.

Results published in the September, 30, 2015, issue of the International Journal of Pharmaceutics revealed that 75% of liposomes remained intact in low bile salt concentrations for up to 90 minutes. In contrast, only 10% were still intact at high bile salt concentrations. Both the low and high concentrations were within the range that is natural in a normal human stomach.

The investigators wrote that, "Our findings showed that crude archaeal lipid extracts have, to a certain extent, stabilizing effects on liposomes similar to purified tetraether lipid fractions tested previously."

Related Links:

University of Southern Denmark



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.